Medicine & Life Sciences
Leishmania donovani
100%
Leishmania
94%
Visceral Leishmaniasis
70%
miltefosine
68%
Parasites
62%
Antimony
30%
Leishmaniasis
27%
Leishmania braziliensis
26%
Drug Resistance
21%
Cutaneous Leishmaniasis
21%
Pharmaceutical Preparations
20%
Genome
20%
Nepal
20%
HSP70 Heat-Shock Proteins
17%
Metabolomics
17%
Treatment Failure
16%
Genes
15%
Infection
14%
Polymerase Chain Reaction
14%
Paromomycin
11%
Population
10%
Leishmania infantum
10%
Epidemiology
9%
India
9%
Kinetoplast DNA
9%
Gene Dosage
9%
Therapeutics
9%
Genomics
8%
Peru
8%
Trypanosoma congolense
8%
African Trypanosomiasis
7%
Trypanosomiasis
7%
Trypanosoma
6%
Metabolome
6%
Phenotype
6%
Aneuploidy
6%
Microsatellite Repeats
6%
Chromosomes
6%
Macrophages
6%
Interleukin-10
5%
Schistosoma
5%
HIV
5%
Parasite Load
5%
Antimony Sodium Gluconate
5%
Genetic Recombination
5%
Somalia
5%
Genotype
5%
Senegal
5%
Skin
5%
Agriculture & Biology
Leishmania donovani
25%
Leishmania
14%
visceral leishmaniasis
11%
antimony
10%
parasites
10%
Leishmania braziliensis
8%
promastigotes
6%
drugs
5%
drug resistance
5%